LF

prof. MVDr. Martina Bago Pilátová, PhD.   SK

Email:
martina.pilatova@upjs.sk
Homepage:
https://www.upjs.sk/LF/zamestnanec/martina.pilatova
Faculty:
LF UPJŠ - Pavol Jozef Šafárik University in Košice Faculty of Medicine
Department:
UFR - Department of Pharmacology
Office:
MA3O11
Phone:
+421 55 234 3251
ORCID ID:
0000-0002-9592-063X
Doc. MVDr. Martina Bago Pilátová, Ph.D. works as an associate professor at the Department of Pharmacology at the UPJŠ Faculty of Medicine in Košice. She is a co-guarantor of the doctoral study program in medical pharmacology in the field of pharmacy. She has supervised 12 successfully defended diploma theses and was the supervisor of 2 successfully completed doctoral students and a consultant for 3 successfully defended doctoral thesis in the study program Pharmacology. She is currently a supervisor of 3 doctoral students, 2 of whom are after the minimum exam. As part of her research, she focuses on the antiproliferative effect of natural substances and their synthetic derivatives, focusing on the study of their possible mechanism of action. She is constantly involved in solving projects in the given area as a responsible solver and co-solver, a complete overview can be found on the website of the department in the Research section. She is the author or co-author of 72 full-text scientific and professional publications published in domestic and foreign journals, 45 of which are registered in CC, WoS or Scopus databases, which have been cited more than 483 times in WoS / Scopus citation indexes. As a co co-author, she has participated in the preparation of textbooks for medical and pharmaceutical students.

Higher education and further qualification growth
Second degree of higher education:
University of Veterinary Medicine, Košice, 2001, Food hygiene
Third degree of higher education:
P. J. Šafárik University in Košice, Faculty of Medicine, 2005, Pharmacology
Associate professor:
P. J. Šafárik University in Košice, Faculty of Medicine, 2012, Pharmacology
Professor:
P. J. Šafárik University in Košice, Faculty of Medicine, 2025, Pharmacology

Research /art/ teacher profile

Display details  
Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
Study programme: Farmakológia 1, 2, study field: VL, II. degree
Study programme: Pharmacology 1, 2, study field: GM, II. degree
Study programme: Pharmacology, study field: Pharmacy, III. degree
Profile courses
Farmakológia 2 - VL, II. degree
Pharmacology 2 - General Medicine, II. degree
Pharmacology 2 - DM, II. degree
Pharmacology - Pharmacology, III. degree
Farmakológia 2 - ZL, II. degree
Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
Name of the field of habilitation procedure and inaugural procedure: Pharmacology, study field to which it is assigned: Pharmacy
Selected publications

V3 - Martina Bago Pilátová, Solárová Zuzana, Mezencev Roman, Solár Peter: Ceramides and their roles in programmed cell death. Advances in Medical Sciences 2023, 17, 417-425. (2023: 2.5 - IF, Q2) cit. 42x

V3 - Nosálová N, Kešeľaková A, Kello M, Martinková M., Fabiánová D, Bago Pilátová M*. „Involvement of both extrinsic and intrinsic apoptotic pathways in tridecylpyrrolidine-diol derivative-induced apoptosis in vitro“ Int J Mol Sci 2023, 24, article number 130803, 1?20, V3, (2023: 4.9 - IF, Q1 - JCR, Q1 - SJR) cit. 9x

ADC- Bogdanová A., Kello M., Macejová A., Nosalová N., Petik P., Takáč P., Martinková M., Mezeiová E., Mirossay L., Gál P., Bago Pilátová M.* Jaspine B hydrochloride-induced apoptosis in HeLa cells is associated with disrupted shingolipid metabolism and ceramide overload.“ Anticancer Res 2021, 41, 2875-2883 (6), ADC (2020: 2.48 - IF, Q2 - JCR, Q2 - SJR) cit. 5x

V3 - Majirská M, Kudličková Z, Nosálová N, Martin Kello, Radka Michalková, Sabolová D, Tvrdoňová M, Jáger D, Bago Pilátová M, Vojtek M, Diniz Pereira C. „Discovery of anticancer indole-based 4,5-dihydroisoxazole derivative with selectivity toward leukemia cells“ ACS pharmacology & translational science 2025, ISSN 2575-9108. - Roč. 8, č. 8 (2025), s. 2507-2525 V3 (2025: 3.7 - IF, Q1 - JCR, Q1 - SJR) cit. 3x

V3 - Majirská M, Bago Pilátová M*, Kudličková Z, Vojtek M, Diniz C.. “Targeting hematological malignancies with isoxazole derivatives” Drug Discov Today 2024, 29, 1–23, V3, (2023: 6.5 - IF, Q1 - JCR, Q1 - SJR) cit. 1x

Selected projects

VEGA 1/0617/22

SLAMF Receptors in Chronic Lymphocytic Leukemia – Potential Targets for Anticancer Therapy. Principal Investigator: PharmDr. M. Šarišský, PhD.; Deputy Project Leader: Doc. MVDr. Martina Bago Pilátová, PhD.

Synthesis and In Vitro Biological Profile of Novel Stereoisomeric Diamino Analogues of Natural D-ribo-Phytosphingosine. Principal Investigator: RNDr. M. Martinková, PhD.; Deputy Project Leader: Doc. MVDr. Martina Bago Pilátová, PhD.

International mobilities and visits
Cancer Research Centre, Salamanca, Spain, January - April 2003, Erasmus Fellowship
European Society for Clinical Cell Analysis (ESCCA), ESCCA (European Society for Clinical Cell Analysis - Amsterdam, Netherlands), Athens, Greece, September 2005, 1st. European course of clinical cytometry
European Society for Clinical Cell Analysis (ESCCA), ESCCA (European Society for Clinical Cell Analysis - Amsterdam, Netherlands), Antwerp, Belgium, September 2007, 3rd. European course of clinical cytometry

Additional information

Further information


LF